Search
for
Sort by
Research 61–90 of 1000+
- Highlights
- The Itchy Scalp
- PRAME Expression in Mammary and Extramammary Paget Disease
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 1. Medical Practice; Therapy; Adverse Reactions
- Contents
- Contents
- MicroRNA in skin diseases
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Atlas of Geriatric Dermatology
- Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health
- Dermoscopy of an osteonevus of Nanta
- Dermatological Drugs, Topical Agents, and Cosmetics
- Scoring systems for pemphigus
- Coloration in Equine: Overview of Candidate Genes Associated with Coat Color Phenotypes
- Polymeric Nanohydrogel in Topical Drug Delivery System
- Dermoscopy Research—An Update
- Scalp melanoma: Distinctive high risk clinical and histological features
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- Primary Cicatricial Alopecia Successfully Treated with A Combination of Oral Zinc with Nd: YAG Laser. A Case Series of Five Patients
- 571 Role of observation for excisionally biopsied moderately dysplastic nevi with positive histologic margins and risk of development of future melanoma
- Sun-protection behaviors of melanoma survivors
- Cutaneous drug reactions
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Cutaneous Reactions to Drugs
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape